Dopamine Control of Gene Expression in Basal Ganglia Nuclei: Striatal and Nonstriatal Mechanisms

Advances in Pharmacology

Volumn 42, Issue C, 1997, Pages 674-677

  Chesselet, M F ^a   Delfs, J M ^a   Mackenzie, L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956740975     PISSN: 10543589     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1054-3589(08)60838-8     Document Type: Article

References (6)

1. Angulo J.A., and McEwen B.S. Molecular aspects of neuropeptide regulation and function in the corpus striatum and nucleus acumbens. Brain Res. Rev 19 (1994) 1-28
2. Albin R.L., Young A.B., and Penney J.B. The functional anatomy of basal ganglia disorders. Trends Neurosci 12 (1990) 366-375
3. Delfs J.M., Anegawa N.J., and Chesselet M.F. Glutamic acid decarboxylase mRNA in rat pallidum: Comparison of the effects of haloperidol, clozapine and combined haloperidol-scopolamine treatments. Neuroscience 66 (1995) 67-80
4. Delfs J.D., Ellison G.D., Mercugliano M., and Chesselet M.F. Expression of glutamic acid decarboxylase mRNA in striatum and pallidum in an animal model of tardive dyskinesia. Exp. Neurol 133 (1995) 175-188
5. Delfs J.D., Ciaramitaro V.M., Parry T.J., and Chesselet M.F. Subthalamic nucleus lesions: Widespread effects on changes in gene expression induced by nigrostriatal dopamine depletion in rats. J. Neurosci 15 (1995) 6562-6575
6. Delfs J.D., Ciaramitaro V.M., Soghomonian J.J., and Chesselet M.F. Unilateral nigrostriatal lesions induce a bilateral increase in glutamic acid decarboxylase mRNA in the reticular thalamic nucleus. Neuroscience 71 (1995) 383-395